Tag: #Global Trends

On March 23, 2026, CVC Capital Partners (CVC) announced that an investor group led by Apollo-managed funds has agreed to... Read more

On March 23, 2026, Swiss pharma giant Novartis announced plans to invest over 3.3 billion Chinese yuan (approximately $480 million)... Read more

On March 20, 2026, AstraZeneca announced its plans to establish a commercial cell therapy manufacturing base and an innovation center... Read more

On March 19, 2026, Roche Pharma India signed a Memorandum of Understanding (MoU) with the National Institute of Pharmaceutical Education... Read more

On March 19, 2026, SK pharmteco, a leading Contract Development and Manufacturing Organization (CDMO), announced a strategic $100 million funding... Read more

On March 19, 2026, Seattle-based biopharmaceutical firm Atossa Therapeutics officially announced the addition of two key figures to its clinical... Read more

On March 20, 2026, Novartis announced an agreement with Synnovation Therapeutics to acquire Pikavation Therapeutics, the subsidiary holding the SNV4818... Read more

On March 20, 2026, Swiss pharmaceutical giant Roche officially announced the discontinuation of emugrobart, an experimental antibody aimed at treating... Read more

On March 20, 2026, Earendil Labs—a biotechnology startup with operations in both the U.S. and China—announced the successful closing of... Read more